A portable, hand-held clinical analyzer measuring electrolytes, glucose, blood urea nitrogen (BUN) and hematocrit has become widely available (iSTAT, Princeton, NJ).
MATERIALS AND METHODS
The iSTAT portable clinical analyzer measures six analytes in human whole blood using a lightweight (1 lb) analyzer and disposable cartridges, delivering quantitative results from a small sample (.065 mL) in less than 2 minutes. Sodium (Na), potassium (K) and chloride (Cl) are measured by ion-selective electrode potentiometry. Blood urea nitrogen is measured by an ion-selective electrode after hydrolysis of urea to ammonium ions. Glucose is measured amperometrically after glucose is oxidized by glucose oxidase, yielding hydrogen peroxide, which is oxidized at the electrode to produce a current proportional to the sample glucose concentration. The hematocrit is measured conductometrically, and the hemoglobin is calculated from the hematocrit. A group of six highly motivated paramedics were fully instructed in the use of the analyzer: quality control reference electrolyte and hematocrit solution analysis, electronic quality control, and analysis of whole blood.
In phase 1, which lasted 1 week, multiple analyses of control solutions (Level 1 + Control: Na + = 115, K + = 5.63, Cl -= 78.7, BUN = 3.8, glucose = 60.1, hematocrit = 30.4; Level 3 + Control: Na + = 142.5, K + = 2.74, Cl -= 106.1, BUN = 64.4, glucose = 205.5, hematocrit = 54. 4 [iSTAT, Princeton, NJ, and MeterTrax Hemoglobin High and Low Level, Hematronix, Benicia, CA) were performed in a moving ambulance to determine performance precision.
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Hand-held portable clinical analyzers permit the rapid measurement of whole blood electrolytes, glucose, blood urea nitrogen (BUN) and hematocrit. Knowledge of these values in the field might aid radio telemetry emergency department physicians in the field treatment and triage of patients. The purpose of this study was determine if the analyzer could function in the hostile prehospital environment. In phase 1, analyses of control electrolyte (n = 30) and hematocrit (n = 28) solutions were performed in a moving ambulance by paramedics to determine precision performance. The F-statistic was used to compare variances against reference values and no significant differences were found. In phase 2, prospective split-sample testing of 57 whole blood samples drawn in the field were analyzed on 2 machines by paramedics in a moving ambulance, and then again within 10 minutes of arrival at the receiving hospital emergency department. Regression analysis between ambulance and emergency department venues revealed high correlation In phase 2, which lasted 3 months, prospective splitsample method comparison testing was performed. Paramedics compared values obtained from iSTAT tests performed in a moving ambulance to those obtained on the same sample analyzed on the same iSTAT devices upon arrival in the emergency department. A convenience sample of excess patient blood was drawn in the field into lithium heparin blood tubes (Vacutainer, Becton Dickinson, Franklin Lakes, NJ). This method of blood drawing is routine when paramedics insert intravenous lines in the field under orders from their radio medical command physician.
When "Out-of-Temperature Errors" occurred, indicating that the iSTAT was outside its specified operating temperature range (64 °F-86 °F), an insulated, warming custom carrying case (HotSak, Comack, NY) was used. This case resists temperature change and was fitted with electric heating elements made to our specifications so as to keep the inside temperature approximately 75°F. This solved the "Out-of-Temperature Error" problem.
Data were collected, entered onto a database (Paradox 4.5, Borland International, Scotts Valley, CA) and analyzed using ParaStat (Financial Modeling Specialists, Vienna, VA) and SPSS/PC+ (SPSS, Chicago, IL). Phase 1 analysis consisted of comparing field values with typical precision performance data using the F-statistic. The Fstatistic was selected because it compares the variance ratio of the samples and permits the determination of whether the observed difference is the result of chance or represents a statistically significant difference. 3 Regression analysis was performed on phase 2 data. This study was approved by our institution's Human Subjects Committee. Informed consent was waived because no patient identifiers were obtained at any point in the study and the amount of excess blood (0.065 mL) was considered incidental.
RESULTS
A total of 458 tests were done in a moving ambulance and 126 in the emergency department during both phases of the study. Thirty analyses were run with each of the control electrolyte (Level 1, Level 3) and hematocrit (high, low) solutions (n = 356 tests: 30 ! 5 Level 1; 30 ! 5 Level 3; 28 high hematocrit; 28 low hematocrit). No significant differences were noted when comparing values obtained in the moving ambulance against the reference values found in the iSTAT manual for typical standard deviations. F-statistic analysis compared the observed variance of values obtained in the ambulance with the typical variance as doucmented in the iSTAT manual (Table 1) .
Fifty-seven patient samples (114 split samples yielding 228 tests) were obtained during phase 2. These data indicate excellent correlation between values obtained in the field on the moving ambulance and those obtained in the hospital emergency department, with correlation (r) values ranging from 0.89 for Cl and 0.99 for K, BUN and glucose (Table 2) . Regression line statistics were calculated for each analyte. These are presented in Table 2 No errors were noted after institution of the HotSak insulating, heating case (HotSac). The alpha error was set at 0.05 and the beta error was set at 0.10. The power of this study to detects to detect a ≥10% difference was calculated. For all control solution analysis, the power was excellent, 1.00. For patient sample Na + the power was excellent, 1.00. For patient sample K + the power was moderate, 0.64. For patient sample BUN the power was low, 0.16. For patient sample glucose the power was moderate, 0.42. The large standard deviation of values partially accounts for the lower power in K + , BUN, and glucose.
DISCUSSION
The recent development of a hand-held whole blood chemistry analyzer has made mobile, rapid analysis possible, known as point-of-care testing. 1, 2, 4 This may prove to be especially helpful in settings where immediate availability of whole blood chemistry and hematocrit results can prove invaluable in treating critically ill and injured patients (intensive care unit, operating room, emergency department). Point-of-care testing has been shown to reduce the length of stay in the emergency department for more than 17% of patients and influenced the admit or discharge decision in more than 10% of patients. 4 We reasoned that if these devices could be shown to reliably function in the hostile prehospital environment in ground ambulances, the data may give paramedics and emergency physicians additional information to aid in the treatment of patients. Perhaps even more important in the future of health care systems where emphasis will be on managed care, the objective data pro-vided by rapid, field blood chemistry, and hematocrit might permit physicians to triage only those patients who need expensive emergency department care to that setting while permitting other patients to be transported to less costly ambulatory care clinics or community health centers. This triage would be partially based on field blood chemistry and hematocrit values that have been shown to be just as reliable as those obtained in the hospital laboratory.
The iSTAT portable clinical analyzer proved to be unaffected by ambulance movement and was accurate during method comparison testing on patient blood samples in moving ambulances versus the emergency department. The instrument operation was straightforward. After appropriate instruction, paramedics easily performed quality assurance procedures on control solutions and processed blood samples in the uncontrolled prehospital setting in less than 2 minutes. We did not believe it was necessary to perform standard in-hospital laboratory testing to validate the iSTAT results because such validation has already been performed (ie, the device is FDA approved and extensive data validating the iSTAT against standard in-hospital laboratory correlation is already in the literature). 9 A limitation of the instrument is the narrow temperature range for operation (64 °F-86 °F). Such temperatures are rarely achieved in the field. To mitigate this problem, a insulated, heated carrying case was custom fabricated to our specifications. The case resisted changes in environmental temperature, holding iSTAT devices within the case at 75 °F. Use of this device eliminated out-of-temperature errors and is mandatory for i-STAT to reliably function in the field. The study was performed in the Winter/Spring (March, April, May) where low temperatures are more common, hence the need for a warming device. Because the HotSak is insulated, we suspect its use will avoid "out-of-temperature" errors from heat as well.
Out-of-hospital testing is becoming more prevalent. Many diabetics use glucometers at home to monitor glucose levels by finger-stick. In Europe, sports trainers perform finger-stick lactate determinations on athletes to assess their endurance. The extension of whole blood chemistry determination to the field with paramedics is the next logical progression of this technology. However, the out-of-hospital venue for whole blood chemistry analysis was not envisioned by laboratory quality control laws (CLIA) and awaits clarification by these authorities.
Armed with the knowledge that blood chemistries and hematocrit can rapidly and reliably be obtained by paramedics in the field, it is now appropriate that clinical pathologists encourage emergency medical service (EMS) medical directors and emergency medicine physicians consider deploying this technology on advanced life support paramedic units to determine its role in prehospital care. High yield criteria for chemistry abnormalities have been developed for medical 6, 7, 8 and trauma 9 patients. Thus selective, criteria-based usage will limit unnecessary test utilization. Knowledge of a patient's chemistries and hematocrit may permit physicians to triage patients to less costly care venues such as ambulatory care centers or community health centers when they have normal chemistry or hematocrit values. This will off-load busy emergency departments choked with patients "waiting for labs" to permit disposition decisions thus decreasing the cost of medical care. Managed care groups will also be interested in the findings of this study since more cost effective triage from the field will lower the cost of medical care, while in no way compromising quality of care because this study has shown the results obtained from iSTAT in the field compare favorably to results obtained in the emergency department. The stage is now set for EMS medical directors to use this technology and study its place, if any, in the treatment and triage of prehospital patients. To justify the additional cost of analysis cassettes (less than $10 each), the information obtained in the field must be shown to have a substantive impact on patient treatment or disposition (triage) to make it cost effective and worth widespread adoption as a prehospital standard of care.
During phase 2 trials, split sample analysis was performed in the ambulance. Paramedics reported that the instrument was easy to use and performed its analysis unattended. The instrument "remembered" the results and was able to re-display results with a single keystroke. All paramedics reported that analysis was easily and rapidly while not being intrusive of patient-care time.
Conclusions
Hand-held whole blood chemistry analysis by paramedics is possible in the hostile prehospital environment. The values obtained in the field are reliable and compare favorably with values obtained in the emergency department. Clinical pathologists should consider working together to determine the correct place for this important modality in the prehospital care of patients by paramedics. Future work should center on emergency physicians and clinical pathologists establishing the role this important modality will play in prehospital paramedic armamentarium and help determine its role in diagnosing, treating, and triaging patients in the field using radiotelemetry links to paramedics. Field blood chemistry determination may have an important role in the managed care venue by providing objective data on which emergency physicians can decide which patients should be transported to the emergency department, the ambulatory care setting, or community health center. As managed care places greater emphasis on reduced use of expensive in-hospital, emergency room and out-patient clinic resources, novel instruments and approaches such as out-of-hospital laboratory analysis of whole blood may prove to be a unique way to maximize the field treatment of patients, safely addressing their needs while avoiding costly hospital-based care when this is not needed.
